[Reteplase. A new thrombolytic agent in the treatment of acute myocardial infarction].
Jurlander
B
B
Rigshospitalet, medicinsk afdeling B. jurlander@post4.tele.dk
Grande
P
P
D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000008:administration & dosage* / Q000737:chemistry / Q000494:pharmacology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; C087896:reteplase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator
Reteplase. Et nyt trombolytikum til behandling af akut myokardieinfarkt.